Skip to main content

Almost a third of women in their 20s have never been screened for cervical cancer

Aug. 27, 2026
Kalyani
Dr. Kalyani Sonawane's work spotlights how many women are not getting screened for cervical cancer. Photo by Clif Rhodes

The percentage of women in their 20s who have never been screened for cervical cancer has been increasing at a disturbing rate over the past 20 years – to the point that now, almost a third of women between the ages of 21 and 29 have never been screened.

The increase is troubling, said researchers at MUSC Hollings Cancer Center, who published their work in JAMA Network Open this week.

Cervical cancer is one of the most preventable cancers, with human papillomavirus (HPV) vaccination as the first line of defense and regular screening as the next.

Yet even among women between the ages of 30 and 64, almost 15% have never been screened, this new paper detailed.

“A lot of times national surveys look at the up-to-date rate, meaning how many women are up to date on their screening,” explained first author Kalyani Sonawane, Ph.D., assistant director for data science and analytics at Hollings. “But this paper is slightly different because it measures the proportion of women who reported that in their lifetime, they've never received screening.”

The researchers relied on self-reported data from the National Health Interview Survey, so there is a chance that some women misremembered whether they’d been screened.

The lack of screening – increasing by 5% each year – was accompanied by an increase in distant- and regional-stage cervical cancer diagnosed in women between the ages of 30 and 64. The goal of screening is to find precancer and early-stage cancer, when it’s easier to treat. It’s possible that, because fewer women are being screened, cancer is now more likely to be diagnosed after it has spread, once a woman notices symptoms and goes to the doctor – however, this study was not designed to investigate how these two trends are related. The researchers mention the increase in regional and distant cancer diagnoses to indicate where more research is needed.

The researchers also note that a substantial proportion of women in their 20s – 45% – are not vaccinated against HPV, meaning they aren’t protected by either the first line of defense or the second.

Sonawane said the research team wasn’t sure why the unscreened rate has been on the upswing. In previous unpublished work, they looked at women’s answers to a question about why they weren’t screened. Many said they didn’t have a particular reason or that their healthcare provider didn’t bring it up.

She also speculated that perhaps some women who are vaccinated against HPV think that means they don’t need screening, though guidelines recommend screening even after vaccination.

The research also uncovered particular gaps in screening. Uninsured women, women living in the South and racial minorities were especially likely to have never been screened.


Cervical cancer screening recommendations:

  • Ages 21 to 29: Pap test every three years.
  • Ages 30 to 65: HPV/Pap co-testing every five years.

The above recommendations are general guidelines for the average-risk woman. Each woman should speak with her healthcare provider about the screening schedule that is best for her as an individual.


Featured in this story

Kalyani "Kelly" Sonawane, Ph.D.

Assistant Director, Data Science and Analytics, Hollings Community Outreach and Engagement Associate Professor, Public Health Sciences

Reference

Sonawane K, Damgacioglu H, Amboree TL, et al. Rates of Never Receiving Cervical Cancer Screening Among US Women, 2005-2023. JAMA Netw Open. 2026;9(8):e2631550. doi:10.1001/jamanetworkopen.2026.31550.

Research reported in this publication was supported by the US National Library of Medicine under award number G08LM014413 and the National Cancer Institute under award number R01CA282424. Additional support came from the National Cancer Institute under award numbers P30CA138313 and R25CA310466.

Meet the Author
Leslie Cantu Hollings Cancer Center Staff wearing a blue dress shirt

Leslie Cantu

Senior Communications Manager

Leslie Cantu is the senior communications manager at MUSC Hollings Cancer Center, where she works with researchers, clinicians and patients to tell the people of South Carolina about the innovative work being done to improve cancer care for everyone in the state. She joined the MUSC Office of Communications and Marketing in 2018 after a career as an award-winning writer, editor and producer at community newspapers and local TV news. She transferred to the communications office at Hollings in 2022, where she happily finds something new and interesting to write about every day. Her favorite stories to cover at MUSC have included Match Day, the Angel Tree Parade, a clinical trial of CAR-T cell therapy and the many patients who have agreed to share their very personal struggles and triumphs.

Contact Leslie at cantul@musc.edu

Recent Cancer Prevention stories